The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.00
Bid: 236.00
Ask: 243.00
Change: 4.00 (1.65%)
Spread: 7.00 (2.966%)
Open: 240.00
High: 246.00
Low: 240.00
Prev. Close: 242.00
PCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Palace Capital (PCA): Strong trading update

22 Apr 2021 16:40

Hardman & Co Research Hardman & Co Research: Palace Capital (PCA): Strong trading update 22-Apr-2021 / 16:40 GMT/BST


Hardman & Co Research: Strong trading update

December 2020 quarter rents showed 92% received; as of the 14 April trading update, 82% of the rents due end-March under the monthly payment plans had been received - a good initial profile. Hudson Quarter (HQ) sales are progressing well into a robust market, and the leisure assets have seen several new lettings. It is also encouraging to see ongoing small, non-core disposals at above book. In addition, cash and facility headroom are more than adequate, at £14.4m, and the company's strategy and its execution remain attractive after the test of COVID-19. The largest segment is regional offices, and there is a positive upside opportunity here for 2021, we believe.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/strong-trading-update/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mike Foster

+44(0)20 3693 7075

 

mf@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1187869 22-Apr-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m
26th Jul 20232:15 pmRNSResult of AGM
26th Jul 20237:00 amRNSAGM Trading Update
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSShare Buyback and Total Voting Rights
30th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 202311:21 amRNSShare Buyback
15th Jun 20237:00 amRNSResults for the year ended 31 March 2023
6th Jun 20237:00 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
15th May 20237:00 amRNSTransaction in Own Shares
12th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSIndustrial properties disposal and Trading Update
18th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20232:30 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.